Plimsoll

Close

Close

Book a FREE no obligation demo with one of our specialists to see how Plimsoll can help you

 

Book a free Demo

Charles river laboratories edinburgh ltd

East Lothian. Registration No: SC091725

  • Registration Number

    SC091725

  • Incorporation Date

    18/02/1985

  • Last Annual Return

    Not available

  • Address

    Elpinstone Research Centre, Tranent, East Lothian. EH33 2NE

  • Website

    www.criver.com

  • Audit Fees

    £280,000

  • Secretary

    Ms Rushna Tejani Heneghan

Directors

Active

Mr Brian Bathgate (65 yrs)

Active

Ms Rushna Tejani Heneghan (62 yrs)

Active

Dr Geoffrey Burns (61 yrs)

Company

Industry Av.

Proposed

Proposed
Year
Period Ending 26-Dec-20 25-Dec-21 31-Dec-22 30-Dec-23 28-Dec-24
Weeks 52 52 53 52 52
Total Sales (£000) 98739 110355 125232 147065 173537
Directors Fees 389 419 413 459 551
Gross Profits 31636 39817 44213 54739 64592
Value Added 68592 82411 89338 107284 133278
Trading Profit 22373 31444 33255 44977 66440
Depreciation 4967 5472 6310 7470
Non-Trading Income 288 2194 1840 1620 0
Total Interest Charges 23 105 43 73 88
Pre-tax Profit 17671 28061 28742 39054 57388
Retained Profit (Shareholders Funds) 17159 16604 6225 12911 23432
Fixed Assets 44121 48043 57060 66119 79343
Intangibles 0 0 0 0 0
Intermediate Assets 21627 29965 32014 28049 33659
Stocks 1404 1910 2348 3722 4392
Debtors 22570 27407 28450 19652 23189
Cash or Equivalent 19243 21039 28488 44679 57305
Total Current Assets 43217 50356 59286 68053 84886
Creditors 4390 28323 38267 6647 9020
Short Term Borrowing 2395 1592 3766 3025 0
Other Current Liabilities 37789 12780 11579 44038 52846
Total Current Liabilities 44574 42695 53612 53710 61866
Net Current Assets -1357 7661 5674 14343 23020
Shareholders Funds 52377 68981 75206 88117 111549
Total Loan Capital 12014 23 0 0 0
Other Capital Employed 0 16665 19542 20394 24473
Total Capital Employed 64391 85669 94748 108511 136022
Pretax Profit Margin % 17.9 25.43 22.95 26.56 33.07
Sales Growth % 14 12 13 17 18
Pretax Profit Growth % 78 59 2 36 46.95
Debtor Ratio Days 83 90 84 49 48.6405874953252
Creditor Ratio Days 16 93 113 16 18.919757930167
Stock Turnover 70 58 53 40 39.5123589468028
Sales £000 / Employee 85 88 93 107 117.481118373275
Value Added £000/Empl. 59 66 66 78 90.2267272257298
Av. Remun. £000 / Empl. 40 41 42 45 45.2483660130719
Total Empl. Remu. £000 46219 50967 56083 62307 66838.4181818185
Employees 1167 1249 1344 1377 1477.14545454546
Pretax Profit/Total Assets % 16 22 19 24 29

Company Summary

  • The Plimsoll Chart is high and rising indicating an improvement in financial strength, well above the industry average.
  • Total Sales have increased by 17.4% in the latest year, well above the industry average of -6.4%.
  • The company lies an excellent 5th in terms of Pretax Profits in this industry.
  • Gross Profit Margin is 37.2% in the latest year, well above the industry average of 23.2%.
  • The company is ranked among the fastest growing in terms of sales growth in the latest year.
  • Exports contribute 63% towards the Total Sales of the company.
  • The company has consistently improved pretax profits over the last 4 years.Only 5 other companies achieved this.
  • Pretax Profit Margin is 26.6% in the latest year, well above the industry average of 4.4%.
  • Shareholders received £12.0m in dividends this year, over 31% of the pretax profits of the company.
  • The Trading Stability chart shows a well below average sales return on total assets in the latest year
  • The Profitability chart shows a well above average pretax profit return on total assets in the latest year
  • The company is among the Top 4 companies listed as a Best Trading Partner (see section 1c).
  • The company is among the Top 50 companies listed as a Fastest Growing Company (see section 2.1c).
  • The company is among the Top 12 in terms of Value Added.

Company

Industry Av.

Proposed

Company Summary

The company currently has £147m sales and made £39.1m, by following the proposal plan, sales would rise to £174m and profits would rise to £57.4m.

Key Attractiveness Features

  • PRIVATELY OWNED
  • ADD £147m TO SALES
  • ATTRACTIVE RATING
  • ATTRACTIVE PRICE

Acquisition Attractiveness Rating

  • Low number of shareholders
  • Company is privately owned
  • Low number of directors
  • Sales growth above the industry average
  • Low financial rating
  • High gross earnings
  • Big difference between current and future value
  • Directors fees represent high proportion of profits
  • Average age of directors is high
Acquisition Attractiveness
  • Highly Attractive
  • Worth Considering
  • Unattractive

Company Valuation

Proposed
Year
Period Ending 26-Dec-20 25-Dec-21 31-Dec-22 30-Dec-23 28-Dec-24
Total Sales (£000) 98739 110355 125232 147065 173537
Pre-tax Profit (£000) 17671 28061 28742 39054 57388
Total Value (£000) 178697 239280 256662 307372 430718
Asset Value (£000) 89722 107325 119872 117542 140583
Goodwill (£000) 88975 131955 136790 189830 290135
Liabilities (£000) -37345 -38344 -44666 -29425 -29034
Equity Value (£000) 141352 200936 211996 277947 401684

Total Value Formula: (Pretax Profit + Interest Payments - Non Trading Income + Directors Fees) * 5 plus (Fixed Assets + Intangibles + Intermediate Assets + Stocks + Debtors)

Shareholders / Ownership

CHARLES RIVER LABORATORIES MONTREAL INC (100.0%)

Immediate Shareholder: See Shareholders

Subsidiaries

None

Acquisition / Valuation Comments

This company has been established 40 years.

The number of shareholders is low (1)

3 directors are over 60 years of age.

The value of the company has risen in each of the last 2 years.

The value of the company has fluctuated in the last 2 years.

The total value of the company is currently £307.4m including debts.

The equity value is high, indicating low levels of total liabilities.

This company is rated HIGHLY ATTRACTIVE in terms of attractiveness.

The proposed year is based on achieving a 29% return on total assets.

The company's value would increase by 40% if the proposed business plan was followed.

The proposed plan would improve the overall financial strength of the company by 17%.

Book a FREE no obligation demo with one of our specialists to see how Plimsoll can help you

 

Book a free Demo
Please select a date and time for a demonstration.